{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:11:11Z","timestamp":1792800671687,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52273157, 52073279, 52025035"],"award-info":[{"award-number":["52273157, 52073279, 52025035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Natural Science Foundation of Jilin Province","award":["20230508102RC, 20240305041YY"],"award-info":[{"award-number":["20230508102RC, 20240305041YY"]}]},{"DOI":"10.13039\/501100004739","name":"Youth Innovation Promotion Association of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2022224"],"award-info":[{"award-number":["2022224"]}],"id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Science and Technology of China","award":["2022YFE0110200"],"award-info":[{"award-number":["2022YFE0110200"]}],"id":[{"id":"https:\/\/ror.org\/02kv4zf79","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03262-9","type":"journal-article","created":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T22:58:41Z","timestamp":1741561121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Platelet hitchhiking vascular-disrupting agents for self-amplified tumor-targeting therapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Hongyu","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuezhan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"3262_CR1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrd3455","volume":"10 6","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 2011;10 6:417\u201327. https:\/\/doi.org\/10.1038\/nrd3455","journal-title":"Nat Rev Drug Discov"},{"key":"3262_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21 10","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21 10:669\u201380. https:\/\/doi.org\/10.1038\/s41568-021-00378-6","journal-title":"Nat Rev Cancer"},{"key":"3262_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","volume":"3 1","author":"I Elia","year":"2021","unstructured":"Elia I, Haigis MC. Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism. Nat Metab. 2021;3 1:21\u201332. https:\/\/doi.org\/10.1038\/s42255-020-00317-z","journal-title":"Nat Metab"},{"key":"3262_CR4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1161\/circresaha.120.316851","volume":"127 2","author":"G Eelen","year":"2020","unstructured":"Eelen G, Treps L, Li X, Carmeliet P. Basic and therapeutic aspects of angiogenesis updated. Circ Res. 2020;127 2:310\u201329. https:\/\/doi.org\/10.1161\/circresaha.120.316851","journal-title":"Circ Res"},{"key":"3262_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ctrv.2010.05.001","volume":"37 1","author":"DW Siemann","year":"2011","unstructured":"Siemann DW. The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by tumor-vascular disrupting agents. Cancer Treat Rev. 2011;37 1:63\u201374. https:\/\/doi.org\/10.1016\/j.ctrv.2010.05.001","journal-title":"Cancer Treat Rev"},{"key":"3262_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nnano.2016.280","volume":"12 4","author":"C Zhang","year":"2017","unstructured":"Zhang C, Ni D, Liu Y, Yao H, Bu W, Shi J. Magnesium silicide nanoparticles as a deoxygenation agent for cancer starvation therapy. Nat Nanotechnol. 2017;12 4:378\u201386. https:\/\/doi.org\/10.1038\/nnano.2016.280","journal-title":"Nat Nanotechnol"},{"key":"3262_CR7","doi-asserted-by":"publisher","first-page":"e2210440","DOI":"10.1002\/adma.202210440","volume":"35 15","author":"X Chen","year":"2023","unstructured":"Chen X, Tang Q, Wang J, Zhou Y, Li F, Xie Y, Wang X, Du L, Li J, Pu J, et al. A DNA\/DMXAA\/Metal-organic framework activator of innate immunity for boosting anticancer immunity. Adv Mater. 2023;35 15:e2210440. https:\/\/doi.org\/10.1002\/adma.202210440.","journal-title":"Adv Mater"},{"key":"3262_CR8","doi-asserted-by":"publisher","first-page":"101673","DOI":"10.1016\/j.nantod.2022.101673","volume":"47","author":"D Wang","year":"2022","unstructured":"Wang D, Feng C, Xiao Z, Huang C, Chen Z, Fang W, Ma X, Wang X, Luo L, Hu K, Tao W. Therapeutic hydrogel for enhanced immunotherapy: A powerful combination of MnO2 nanosheets and vascular disruption. Nano Today. 2022;47:101673. https:\/\/doi.org\/10.1016\/j.nantod.2022.101673.","journal-title":"Nano Today"},{"key":"3262_CR9","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","volume":"11 7","author":"L Corrales","year":"2015","unstructured":"Corrales L, Glickman LH, McWhirter SM, Kanne DB, Sivick KE, Katibah GE, Woo SR, Lemmens E, Banda T, Leong JJ, et al. Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Rep. 2015;11 7:1018\u201330. https:\/\/doi.org\/10.1016\/j.celrep.2015.04.031","journal-title":"Cell Rep"},{"key":"3262_CR10","doi-asserted-by":"publisher","unstructured":"Weiss JM, Gu\u00e9rin MV, Regnier F, Renault G, Galy-Fauroux I, Vimeux L, Feuillet V, Peranzoni E, Thoreau M, Trautmann A. The STING agonist DMXAA triggers a Cooperation between T lymphocytes and myeloid cells that leads to tumor regression. 2017;6 10:e1346765; https:\/\/doi.org\/10.1080\/2162402X.2017.1346765","DOI":"10.1080\/2162402X.2017.1346765"},{"key":"3262_CR11","doi-asserted-by":"publisher","unstructured":"Chen X, Xu Z, Li T, Thakur A, Wen Y, Zhang K, Liu Y, Liang Q, Liu W, Qin JJ, Yan Y. Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy. Biomark Res. 2024;12(1:2). https:\/\/doi.org\/10.1186\/s40364-023-00551-z.","DOI":"10.1186\/s40364-023-00551-z"},{"key":"3262_CR12","doi-asserted-by":"publisher","unstructured":"Liu Z, Zhang Y, Shen N, Sun J, Tang Z, Chen X. Destruction of tumor vasculature by vascular disrupting agents in overcoming the limitation of EPR effect. 2022;183:114138; https:\/\/doi.org\/10.1016\/j.addr.2022.114138","DOI":"10.1016\/j.addr.2022.114138"},{"key":"3262_CR13","doi-asserted-by":"publisher","unstructured":"Hadi MK, Wang X, Peng Y, Sangaraju S, Ran F. Functional Polymeric Membrane Materials: A Perspective from Versatile Methods and Modification to Potential Applications.Polymer Science & Technology. 2024. https:\/\/doi.org\/10.1021\/polymscitech.4c00030","DOI":"10.1021\/polymscitech.4c00030"},{"key":"3262_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.addr.2014.01.005","volume":"74","author":"H Nishihara","year":"2014","unstructured":"Nishihara H. Human pathological basis of blood vessels and stromal tissue for nanotechnology. Adv Drug Deliv Rev. 2014;74:19\u201327. https:\/\/doi.org\/10.1016\/j.addr.2014.01.005","journal-title":"Adv Drug Deliv Rev"},{"key":"3262_CR15","doi-asserted-by":"publisher","first-page":"114614","DOI":"10.1016\/j.addr.2022.114614","volume":"191","author":"R Sun","year":"2022","unstructured":"Sun R, Xiang J, Zhou Q, Piao Y, Tang J, Shao S, Zhou Z, Bae YH, Shen Y. The tumor EPR effect for cancer drug delivery: current status, limitations, and alternatives. Adv Drug Deliv Rev. 2022;191:114614. https:\/\/doi.org\/10.1016\/j.addr.2022.114614.","journal-title":"Adv Drug Deliv Rev"},{"key":"3262_CR16","doi-asserted-by":"publisher","first-page":"8423","DOI":"10.1021\/acsnano.8b03900","volume":"12 8","author":"Q Dai","year":"2018","unstructured":"Dai Q, Wilhelm S, Ding D, Syed AM, Sindhwani S, Zhang Y, Chen YY, MacMillan P, Chan W. Quantifying the ligand-coated nanoparticle delivery to cancer cells in solid tumors. ACS Nano. 2018;12 8:8423\u201335. https:\/\/doi.org\/10.1021\/acsnano.8b03900","journal-title":"ACS Nano"},{"key":"3262_CR17","doi-asserted-by":"publisher","unstructured":"Seidi K, Neubauer HA, Moriggl R, Jahanban-Esfahlan R, Javaheri T. Tumor target amplification: implications for nano drug delivery systems. 2018;275:142\u201361. https:\/\/doi.org\/10.1016\/j.jconrel.2018.02.020","DOI":"10.1016\/j.jconrel.2018.02.020"},{"key":"3262_CR18","doi-asserted-by":"publisher","first-page":"e202218407","DOI":"10.1002\/anie.202218407","volume":"62 12","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Gong P, Wang J, Cheng J, Wang W, Cai H, Ao R, Huang H, Yu M, Lin L, et al. Amplification of lipid peroxidation by regulating cell membrane unsaturation to enhance chemodynamic therapy. Angew Chem Int Ed Engl. 2023;62 12:e202218407. https:\/\/doi.org\/10.1002\/anie.202218407.","journal-title":"Angew Chem Int Ed Engl"},{"key":"3262_CR19","doi-asserted-by":"publisher","unstructured":"Zhu Y, Wang W, Gong P, Zhao Y, Pan Y, Zou J, Ao R, Wang J, Cai H, Huang H. Enhancing catalytic activity of a nickel single atom enzyme by polynary heteroatom doping for ferroptosis-based tumor therapy. 2023;17 3:3064\u201376; https:\/\/doi.org\/10.1021\/acsnano.2c11923","DOI":"10.1021\/acsnano.2c11923"},{"key":"3262_CR20","doi-asserted-by":"publisher","first-page":"e2002094","DOI":"10.1002\/adma.202002094","volume":"33 7","author":"Y Wang","year":"2021","unstructured":"Wang Y, Shen N, Wang Y, Zhang Y, Tang Z, Chen X. Self-amplifying nanotherapeutic drugs homing to tumors in a manner of chain reaction. Adv Mater. 2021;33 7:e2002094. https:\/\/doi.org\/10.1002\/adma.202002094.","journal-title":"Adv Mater"},{"key":"3262_CR21","doi-asserted-by":"publisher","first-page":"e2100241","DOI":"10.1002\/adma.202100241","volume":"33 50","author":"H Pan","year":"2021","unstructured":"Pan H, Zheng M, Ma A, Liu L, Cai L. Cell\/Bacteria-based bioactive materials for cancer immune modulation and precision therapy. Adv Mater. 2021;33 50:e2100241. https:\/\/doi.org\/10.1002\/adma.202100241.","journal-title":"Adv Mater"},{"key":"3262_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.tips.2020.11.008","volume":"42 2","author":"LM Bush","year":"2021","unstructured":"Bush LM, Healy CP, Javdan SB, Emmons JC, Deans TL. Biological cells as therapeutic delivery vehicles. Trends Pharmacol Sci. 2021;42 2:106\u201318. https:\/\/doi.org\/10.1016\/j.tips.2020.11.008","journal-title":"Trends Pharmacol Sci"},{"key":"3262_CR23","doi-asserted-by":"publisher","unstructured":"Jia M, Miao W, Li Y, Guo Y, Zeng J, Gao Y, Li X, Wang Y, Zhao Z, Xu Z, et al. A polymerized probucol nanoformulation with neutrophil extracellular vesicle camouflage for cerebral ischemia-reperfusion injury therapy. Innov. 2024;100761. https:\/\/doi.org\/10.1016\/j.xinn.2024.100761.","DOI":"10.1016\/j.xinn.2024.100761"},{"key":"3262_CR24","doi-asserted-by":"publisher","first-page":"20230164","DOI":"10.1002\/EXP.20230164","volume":"4 6","author":"Y He","year":"2024","unstructured":"He Y, Zhang S, She Y, Liu Z, Zhu Y, Cheng Q, Ji X. Innovative utilization of cell membrane-coated nanoparticles in precision cancer therapy. Exploration. 2024;4 6:20230164. https:\/\/doi.org\/10.1002\/EXP.20230164.","journal-title":"Exploration"},{"key":"3262_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-3-319-95294-9_12","volume":"1092","author":"N Ortiz-Otero","year":"2018","unstructured":"Ortiz-Otero N, Mohamed Z, King MR. Platelet-Based drug delivery for Cancer applications. Adv Exp Med Biol. 2018;1092:235\u201351. https:\/\/doi.org\/10.1007\/978-3-319-95294-9_12","journal-title":"Adv Exp Med Biol"},{"key":"3262_CR26","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41551-018-0310-2","volume":"2 11","author":"Q Hu","year":"2018","unstructured":"Hu Q, Sun W, Wang J, Ruan H, Zhang X, Ye Y, Shen S, Wang C, Lu W, Cheng K, et al. Conjugation of Haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy. Nat Biomed Eng. 2018;2 11:831\u201340. https:\/\/doi.org\/10.1038\/s41551-018-0310-2","journal-title":"Nat Biomed Eng"},{"key":"3262_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-319-95294-9_6","volume":"1092","author":"MR Zanotelli","year":"2018","unstructured":"Zanotelli MR, Reinhart-King CA. Mechanical forces in tumor angiogenesis. Adv Exp Med Biol. 2018;1092:91\u2013112. https:\/\/doi.org\/10.1007\/978-3-319-95294-9_6","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"3262_CR28","doi-asserted-by":"publisher","first-page":"a006429","DOI":"10.1101\/cshperspect.a006429","volume":"2","author":"WC Aird","year":"2012","unstructured":"Aird WC. Endothelial cell heterogeneity. Cold Spring Harb Perspect Med. 2012;2(1):a006429. https:\/\/doi.org\/10.1101\/cshperspect.a006429.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3262_CR29","doi-asserted-by":"publisher","first-page":"e2120633","DOI":"10.1001\/jamanetworkopen.2021.20633","volume":"4 8","author":"V Giannakeas","year":"2021","unstructured":"Giannakeas V, Narod SA. Incidence of Cancer among adults with thrombocytosis in Ontario, Canada. JAMA Netw Open. 2021;4 8:e2120633. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.20633.","journal-title":"JAMA Netw Open"},{"key":"3262_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.thromres.2016.01.006","volume":"139","author":"S Mezouar","year":"2016","unstructured":"Mezouar S, Fr\u00e8re C, Darbousset R, Mege D, Crescence L, Dignat-George F, Panicot-Dubois L, Dubois C. Role of platelets in cancer and cancer-associated thrombosis: experimental and clinical evidences. Thromb Res. 2016;139:65\u201376. https:\/\/doi.org\/10.1016\/j.thromres.2016.01.006","journal-title":"Thromb Res"},{"key":"3262_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/nejm195305072481901","volume":"248 19","author":"M Stefanini","year":"1953","unstructured":"Stefanini M, Dameshek W. Collection, preservation and transfusion of platelets; with special reference to the factors affecting the survival rate and the clinical effectiveness of transfused platelets. N Engl J Med. 1953;248 19:797-802. https:\/\/doi.org\/10.1056\/nejm195305072481901","journal-title":"N Engl J Med"},{"key":"3262_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature15373","volume":"526 7571","author":"CM Hu","year":"2015","unstructured":"Hu CM, Fang RH, Wang KC, Luk BT, Thamphiwatana S, Dehaini D, Nguyen P, Angsantikul P, Wen CH, Kroll AV, et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015;526 7571:118\u201321. https:\/\/doi.org\/10.1038\/nature15373","journal-title":"Nature"},{"key":"3262_CR33","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ame2.12139","volume":"3 4","author":"G Silva-Santana","year":"2020","unstructured":"Silva-Santana G, Bax JC, Fernandes DCS, Bacellar DTL, Hooper C, Dias A, Silva CB, de Souza AM, Ramos S, Santos RA, et al. Clinical hematological and biochemical parameters in Swiss, BALB\/c, C57BL\/6 and B6D2F1 Mus musculus. Anim Model Exp Med. 2020;3 4:304\u201315. https:\/\/doi.org\/10.1002\/ame2.12139","journal-title":"Anim Model Exp Med"},{"key":"3262_CR34","doi-asserted-by":"publisher","first-page":"15319","DOI":"10.1021\/ja508083g","volume":"136 43","author":"M Zhao","year":"2014","unstructured":"Zhao M, Liu Y, Hsieh RS, Wang N, Tai W, Joo KI, Wang P, Gu Z, Tang Y. Clickable protein nanocapsules for targeted delivery of Recombinant p53 protein. J Am Chem Soc. 2014;136 43:15319\u201325. https:\/\/doi.org\/10.1021\/ja508083g","journal-title":"J Am Chem Soc"},{"key":"3262_CR35","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1074\/jbc.M109714200","volume":"277 4","author":"H Chen","year":"2002","unstructured":"Chen H, Locke D, Liu Y, Liu C, Kahn ML. The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion. J Biol Chem. 2002;277 4:3011\u20139. https:\/\/doi.org\/10.1074\/jbc.M109714200","journal-title":"J Biol Chem"},{"key":"3262_CR36","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/ijc.33985","volume":"151 5","author":"R Shi","year":"2022","unstructured":"Shi R, Zhang Z, Zhu A, Xiong X, Zhang J, Xu J, Sy MS, Li C. Targeting type I collagen for cancer treatment. Int J Cancer. 2022;151 5:665\u201383. https:\/\/doi.org\/10.1002\/ijc.33985","journal-title":"Int J Cancer"},{"key":"3262_CR37","doi-asserted-by":"publisher","first-page":"6851","DOI":"10.1158\/0008-5472.Can-08-0718","volume":"68 16","author":"B Ho-Tin-No\u00e9","year":"2008","unstructured":"Ho-Tin-No\u00e9 B, Goerge T, Cifuni SM, Duerschmied D, Wagner DD. Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res. 2008;68 16:6851\u20138. https:\/\/doi.org\/10.1158\/0008-5472.Can-08-0718","journal-title":"Cancer Res"},{"key":"3262_CR38","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1182\/blood-2015-06-650838","volume":"126 8","author":"J Rayes","year":"2015","unstructured":"Rayes J, Watson SP. Platelet GPVI repairs its own damage. Blood. 2015;126 8:933\u20134. https:\/\/doi.org\/10.1182\/blood-2015-06-650838","journal-title":"Blood"},{"key":"3262_CR39","doi-asserted-by":"publisher","first-page":"6866","DOI":"10.1021\/acs.nanolett.2c00582","volume":"22 17","author":"L Zhang","year":"2022","unstructured":"Zhang L, Bo R, Wu Y, Li L, Zhu Z, Ma AH, Xiao W, Huang Y, Rojalin T, Yin X, et al. Programmable bispecific Nano-immunoengager that captures T cells and reprograms tumor microenvironment. Nano Lett. 2022;22 17:6866\u201376. https:\/\/doi.org\/10.1021\/acs.nanolett.2c00582","journal-title":"Nano Lett"},{"key":"3262_CR40","doi-asserted-by":"publisher","first-page":"114238","DOI":"10.1016\/j.addr.2022.114238","volume":"185","author":"W Ngo","year":"2022","unstructured":"Ngo W, Ahmed S, Blackadar C, Bussin B, Ji Q, Mladjenovic SM, Sepahi Z, Chan WCW. Why nanoparticles prefer liver macrophage cell uptake in vivo. Adv Drug Deliv Rev. 2022;185:114238. https:\/\/doi.org\/10.1016\/j.addr.2022.114238.","journal-title":"Adv Drug Deliv Rev"},{"key":"3262_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jconrel.2021.04.016","volume":"334","author":"Y Huang","year":"2021","unstructured":"Huang Y, Wang J, Jiang K, Chung EJ. Improving kidney targeting: the influence of nanoparticle physicochemical properties on kidney interactions. J Control Release. 2021;334:127\u201337. https:\/\/doi.org\/10.1016\/j.jconrel.2021.04.016","journal-title":"J Control Release"},{"key":"3262_CR42","doi-asserted-by":"publisher","first-page":"eabc3646","DOI":"10.1126\/sciadv.abc3646","volume":"6 35","author":"J Liang","year":"2020","unstructured":"Liang J, Wang H, Ding W, Huang J, Zhou X, Wang H, Dong X, Li G, Chen E, Zhou F, et al. Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity. Sci Adv. 2020;6 35:eabc3646. https:\/\/doi.org\/10.1126\/sciadv.abc3646.","journal-title":"Sci Adv"},{"key":"3262_CR43","doi-asserted-by":"publisher","first-page":"e99988","DOI":"10.1371\/journal.pone.0099988","volume":"9 6","author":"CM Downey","year":"2014","unstructured":"Downey CM, Aghaei M, Schwendener RA, Jirik FR. DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical Cyclic dinucleotide STING agonist, 2\u20193\u2019-cGAMP, induces M2 macrophage repolarization. PLoS ONE. 2014;9 6:e99988. https:\/\/doi.org\/10.1371\/journal.pone.0099988.","journal-title":"PLoS ONE"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03262-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03262-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03262-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T22:58:48Z","timestamp":1741561128000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03262-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3262"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03262-9","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In vivo antitumor studies were performed in mice bearing CT26 colorectal or 4T1 breast cancer cells, adhering to the Guide for the Care and Use of Laboratory Animals. All protocols were approved by the Animal Care and Use Committee of the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"197"}}